TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Apr 17, 2026
2 min read
42

OpenAI has reportedly agreed to a significant deal with chip startup Cerebras. The agreement involves OpenAI paying over $20 billion over the next three years to utilize servers powered by Cerebras' processors. As part of this arrangement, OpenAI will also receive an equity stake in the startup through warrants for shares.
The move highlights OpenAI's aggressive strategy to secure the vast computing power required for its advanced AI models. This partnership comes as Cerebras is reportedly preparing to file for an initial public offering. The deal structure, which includes equity, aligns OpenAI's success with that of a key hardware supplier, securing a critical component of its supply chain.
This partnership could intensify competition within the specialized AI hardware market, challenging more established players. It underscores the massive demand for AI-specific infrastructure and may influence future investment and acquisition activities in the semiconductor sector as AI companies seek to vertically integrate or secure long-term capacity.
OpenAI's substantial investment in Cerebras marks a pivotal step in reinforcing its hardware foundation. Market observers will be closely watching the details of Cerebras' potential IPO and the broader implications of this partnership on the competitive landscape of AI hardware development.
Q: What is the total value of the deal between OpenAI and Cerebras?
A: OpenAI has agreed to pay over $20 billion for server use over three years, plus approximately $1 billion to help fund the construction of data centers.
Q: Does OpenAI now own part of Cerebras?
A: Yes, the deal grants OpenAI an equity stake in Cerebras in the form of warrants for a minority portion of the company's shares, with potential for more based on spending.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

01 Mei 2026
Canada Approves Apotex Generic Ozempic Drug

01 Mei 2026
RRE Ventures SPAC Raises $250M in Nasdaq IPO